Observational Study of MLSDT for Macular Degeneration and Stargardt Disease
This observational study is looking at how well a vision test called the MLSDT works for people with vision loss from Stargardt Disease or geographic atrophy (a type of age-related macular degeneration). Researchers want to see if the MLSDT, which uses 9 shapes, is a reliable and accurate way to measure functional vision, both with and without special magnifying glasses (eGlasses). They will compare these results to another common vision test called ETDRS. The study aims to enroll 30 participants, including those with normal vision and those with moderate to severe vision impairment. The main goal is to see how MLSDT scores compare between these groups after 15 days.
- Study design
- This is an observational study involving 30 participants, divided into different groups based on their vision. It is not a randomized or blinded study.
- What's involved
- Participants will undergo MLSDT testing both with and without eGlasses, and ETDRS testing both with and without eGlasses. The primary endpoint is measured at 15 days.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint is measured at 15 days, indicating a short follow-up period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Samuel Barone, MD · STUDY_CHAIR · Nanoscope Therapeutics Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- MLSDT scores in normal and severely visually impaired subjects with a clinical diagnosis of Stargardt Disease or Geographic Atrophy on MLSDT15 days
Comparison of vision test scores against the ETDRS visual acuity test